Team

Dr Benjamin Young MPharm MRPharmS

Ben obtained his Pharmacy Degree with Starred First Class Honours from the University of East Anglia in Norwich, before registering as a Pharmacist with the General Pharmaceutical Council in 2009. He went on to gain a PhD in Medicinal Chemistry from the University of Bath in 2013 under the supervision of Dr Ian Eggleston, which was followed by a nine-month Postdoctoral Research Position at the University. Ben worked at St George’s Hospital in London as an Aseptic Services Pharmacist before returning to the South West to join the R&D team at Bath ASU in October 2014.

Terry Chapman MPharmacol

Terry gained his Master of Pharmacology Degree from the University of Bath in 2014. During his degree he took on an 18 month placement within the research team of Bath ASU. Through his placement he learnt about stability assessment of small molecules and biological pharmaceuticals. He is now undertaking a PhD investigating antibody drug conjugates, specifically regarding characterisation, stability and safety.

Dr Monika Ali Khan

Monika received a MSc (Hons) degree in Organic Chemistry from the University of Wroclaw, Poland. During her diploma thesis she worked on cyclolinopeptides. Her studies included three months as an Erasmus student at the University of Sassari in Sardinia. After her graduation she moved to UK, where she worked at Evotec and then ESG for two years.

From 2008, she carried out doctoral studies in the Lewis group at the University of Bath. Her research focused on the synthesis of novel iron tricarbonyl complexes. In 2012 she obtained a PhD in Organic Chemistry. Subsequently, she worked as a post-doctoral fellow in the same research group. Since November 2013 she is working as a Senior Analytical Scientist at Bath ASU. Outside of work she enjoys swimming, music and chess.

Dr Richard Parry

Richard is a postdoctoral scientist with a particular interest in drugs that interact with the immune system. During his PhD he studied T-lymphocyte co-stimulation with Professor Stephen Ward, which sparked his interest in immuno-pharmacology. He carried out post-doctoral research on therapeutic ex-vivo manipulation of T lymphocyte function with Professor Carl June at the University of Pennsylvania.

He currently works in the Bath ASU Research and Development laboratory determining the stability of immunotherapeutic proteins. He has over ten years of experience in academic and commercial laboratories, and has authored over twenty original research and review articles.

Maria Connolly MPharm MSc MRPharmS

Maria is Director of Quality & Compliance at Bath ASU, Teaching Fellow at the University of Bath and Lecturer at the University of Leeds.

Dr Andy Watts

Andy is a Lecturer at the University of Bath, and is a co-founder of biotech company Glythera.